Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) OCF Yield %: 4.86 (As of Jul. 12, 2026) — 43% Below Median


TPE:1762 Chunghwa Chemical Synthesis & Biotech Co Ltd TPE:1762
58 GF Score
Price NT$38.15
GF Value NT$37.92
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Chunghwa Chemical Synthesis & Biotech Co OCF Yield %?

Chunghwa Chemical Synthesis & Biotech Co TPE:1762 58 OCF Yield % is 4.86 as of Jul. 12, 2026, which is 43% below its 10-year median of 8.55. GuruFocus rates TPE:1762 with a GF Score™ of 58/100 and a GF Value™ of NT$37.92 (Fairly Valued). The stock has 8 warning signs investors should review. Among 1,410 Biotechnology companies, Chunghwa Chemical Synthesis & Biotech Co ranks better than 90% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Chunghwa Chemical Synthesis & Biotech Co's Trailing 12-Month Cash Flow from Operations is NT$142.6 Mil, and Market Cap is NT$2,934.4 Mil. Therefore, Chunghwa Chemical Synthesis & Biotech Co's OCF Yield % for today is 4.86%.

The historical rank and industry rank for Chunghwa Chemical Synthesis & Biotech Co's OCF Yield % or its related term are showing as below:

TPE:1762' s OCF Yield % Range Over the Past 10 Years
Min: -8.96   Med: 8.55   Max: 52.7
Current: 4.86


During the past 13 years, the highest OCF Yield % of Chunghwa Chemical Synthesis & Biotech Co was 52.70%. The lowest was -8.96%. And the median was 8.55%.

TPE:1762's OCF Yield % is ranked better than
90% of 1410 companies
in the Biotechnology industry
Industry Median: -8.26 vs TPE:1762: 4.86

Chunghwa Chemical Synthesis & Biotech Co's OCF Margin % for the quarter that ended in Dec. 2025 was %.


Chunghwa Chemical Synthesis & Biotech Co OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Chunghwa Chemical Synthesis & Biotech Co OCF Yield % Related Terms


Chunghwa Chemical Synthesis & Biotech Co OCF Yield % Historical Data

* Premium members only.

The historical data trend for Chunghwa Chemical Synthesis & Biotech Co's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chunghwa Chemical Synthesis & Biotech Co OCF Yield % Chart

Chunghwa Chemical Synthesis & Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.35 14.42 -1.49 17.79 7.57

Chunghwa Chemical Synthesis & Biotech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.07 12.92 -5.15 22.66 -4.37

TPE:1762 vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, Chunghwa Chemical Synthesis & Biotech Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chunghwa Chemical Synthesis & Biotech Co OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chunghwa Chemical Synthesis & Biotech Co's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Chunghwa Chemical Synthesis & Biotech Co's OCF Yield % falls into.


TPE:1762
58GF Score
Chunghwa Chemical Synthesis & Biotech Co Ltd TPE:1762
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chunghwa Chemical Synthesis & Biotech Co OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Chunghwa Chemical Synthesis & Biotech Co's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=142.611 / 1884.491
=7.57%

Chunghwa Chemical Synthesis & Biotech Co's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-20.593 * 4 / 1884.491
=-4.37%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 4.86 mean?
Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) has a OCF Yield % of 4.86 as of Jul. 12, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Chunghwa Chemical Synthesis & Biotech Co and its competitors. This is 43% below median its historical median of 8.55. According to the industry distribution chart, Chunghwa Chemical Synthesis & Biotech Co ranks #141 out of 1410 companies in the Biotechnology industry, placing it in the top 10%.
Is Chunghwa Chemical Synthesis & Biotech Co's OCF Yield % too high?
Chunghwa Chemical Synthesis & Biotech Co's current OCF Yield % of 4.86 is 43% below median its 10-year median of 8.55. Based on the distribution chart, Chunghwa Chemical Synthesis & Biotech Co ranks #141 out of 1410 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Chunghwa Chemical Synthesis & Biotech Co has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chunghwa Chemical Synthesis & Biotech Co's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chunghwa Chemical Synthesis & Biotech Co ranks #141 out of 1410 companies for OCF Yield %. This places Chunghwa Chemical Synthesis & Biotech Co in the top 10% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Chunghwa Chemical Synthesis & Biotech Co and its competitors. Chunghwa Chemical Synthesis & Biotech Co's current OCF Yield % is 4.86, which is 43% below median its own 10-year median of 8.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chunghwa Chemical Synthesis & Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) is currently considered Fairly Valued. The stock's GF Value™ is NT$37.92, compared to a current price of NT$38.15 — trading 0.6% above its estimated fair value. The current OCF Yield % is 4.86, which is 43% below median its 10-year median of 8.55. Chunghwa Chemical Synthesis & Biotech Co's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Chunghwa Chemical Synthesis & Biotech Co (TPE:1762), the current OCF Yield % is 4.86 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chunghwa Chemical Synthesis & Biotech Co (TPE:1762) Overvalued in 2026?

Based on GuruFocus' analysis, Chunghwa Chemical Synthesis & Biotech Co stock appears to be overvalued. The current stock price of NT$38.15 is trading 0.6% above its estimated GF Value™ of NT$37.92. GuruFocus considers Chunghwa Chemical Synthesis & Biotech Co to be Fairly Valued.

Key valuation signals for TPE:1762:

  • OCF Yield %: 4.86 (43% below median its 10-year median of 8.55)
  • GF Value™: NT$37.92 vs. price of NT$38.15 (0.6% above fair value)
  • GF Score™: 58/100 with 8 warning signs

No single metric tells the full story. See the TPE:1762 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chunghwa Chemical Synthesis & Biotech Co Business Description

Address No. 1, Dongxing Street, Shulin District, Taipei, TWN
Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in the research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of its revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises pain management, antifungal, immunosuppressant, oncology, Cardiovascular, Peptide Drugs, and Others.
58GF Score

Get the complete analysis for TPE:1762

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.15
Price
NT$37.92
GF Value